The initial public offerings market has been slow going for medical device companies in recent years, and it isn’t likely to pick up anytime soon. While the IPO market won’t be completely dead, “companies that I speak with aren’t thinking about IPOs in the near term,” said Jason Mills, managing director of medical devices equity research with Canaccord Genuity. Mills participated in a panel discussion on cardiovascular investing at the Cleveland Clinic Medical Innovation Summit.
